From ACOG - Philadelphia, Pennsylvania - May, 1999
The file you requested will begin playing automatically. If it does not, press the 'play' button. If you experience playback problems, make certain you have the latest version of RealPlayer, available here. If you have the latest RealPlayer and still experience problems, email the OBGYN.net Webmaster with a description of the problem and any error messages you may have received.
FDA adds boxed warning to fezolinetant for rare serious liver injury
Published: December 17th 2024 | Updated: December 17th 2024The FDA has added a boxed warning for fezolinetant (VEOZAH; Astellas), highlighting the rare occurrence of serious liver injury in patients taking the menopause treatment.
Read More